240 likes | 370 Views
This study analyzes microarray data from adenocarcinoma samples, comparing gene expressions across different groups: 62 total surgeries, 38 total bronchoscopies, with smokers and nonsmokers. Key findings showcase the glycolytic pathways in cancer cells linked to mitochondrial injury and therapeutic resistance. Specific genes such as VDAC1, UBE4B, and others are highlighted for their roles in smoker versus nonsmoker comparisons in male and female cohorts. The research underscores the impact of smoking on gene expression in adenocarcinoma for both surgical and bronchoscopic interventions.
E N D
Microarray data analysis of adeno- samples Total Surgery: 62 Adeno: 38 Total bronchoscopy: 110 Adeno: 43 8 Yes vs. 23 No 17 Yes vs. 14 No Male: 5 Female: 18 Male: 6 Female: 2 Male: 3 Female: 13 Male: 15 Female: 3
Male-adeno-(surgery): smokers (6) vs. nonsmokers (5) 26 genes
Male-adeno-(surgery): smokers vs. nonsmokers Cancer cells generally exhibit increased glycolysis for ATPgeneration due in part to mitochondrialrespiration injury and hypoxia, which are frequently associatedwith resistance to therapeutic agents.
Male-adeno-(surgery): smokers vs. nonsmokers VDAC1 UBE4B TRRAP TRM27 RPL5 POLR3C PGK1 ATP6V1A CHRNA5 NR4A2 NONO GNB2L1 POLE4
Male-adeno-(Bronchoscopy): smokers vs. nonsmokers PRKCDBP FJX1 DNM3 COL13A1 APL15 SELE CST4
Male-adeno-(bronchoscopy+surgery): smokers (21) vs. nonsmokers (8)
Female-adeno-(bronchoscopy): smokers (3) vs. nonsmokers (10) 20 genes
Female-adeno-(bronchoscopy+surgery): smokers (31) vs. nonsmokers (5)
GSE10072 nm1790